Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Lupin and Glenmark Pharma are part of the pharma group which is outperforming and may continue. We want to be buyers and only buyers in these on dips and consolidation. There should be no brave hearts trying to short sell any of the pharma companies.""ITC is a different issue. To me the charts were a little indifferent although it is now shaping up quite nicely and fairly bullish but since I am confused on ITC I do not have an opinion," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!